Trial Profile
A randomized double blind comparison between single doses of Symbicort Turbuhaler (budesonide/formoterol combination), formoterol, salbutamol and placebo in repeated AMP-challenges in patients with mild-to-moderate asthma. Investigating the supplementary value of the budesonide component within Symbicort when tested in a model of slow onset acute asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Formoterol; Salbutamol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 02 Feb 2010 Actual end date (Nov 2005) added as reported by ClinicalTrials.gov.
- 15 Aug 2006 Status change
- 29 Mar 2006 New trial record.